Innovation is a key to strengthen Fidia's portfolio and a prerequisite for the success of our customers and partners.
Continually working to identify new treatment opportunities is the framework of our commitment to patients.
High on the company's list of priorities is the study of hyaluronic acid,a molecule that at Fidia means tradition,innovation,excellence.
By modifying its chemistry,new products and innovative drug delivery systems and technology platforms are formulated that consolidate Fidia's leadership in areas such as joint healthcare,advanced wound care and aesthetic dermatology.
Fidia is continually working to identify new opportunities and develop an industry-leading pipeline of promising new treatments for specific pathologies in highly challenging areas,with products covered by international patents,that are a vital part of the company's heritage,as well as innovative formulations that will enhance their characteristics,without compromising the quality of care